Rchr
J-GLOBAL ID:202101008412018120   Update date: Feb. 01, 2024

Kudo Naomi

クドウ ナオミ | Kudo Naomi
Affiliation and department:
Research theme for competitive and other funds  (5):
  • 2022 - 2025 モデル動物による好酸球性中耳炎の難治化と内耳障害の研究
  • 2021 - 2025 マイクロバイオーム解析による上気道難治性アレルギー性・好酸球性炎症の病態解明
  • 2019 - 2022 Investigation for inner ear pathology of eosinophilic otitis media with animal model
  • 2016 - 2019 Multilateral study on the pathophysiology of eosinophilia otitis media
  • 2012 - 2015 An elucidation of pathological condition and development new treatment strategy for eosinophilic otitis media using animal model.
Papers (8):
  • Ryuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, Shin Kariya, Tomoya Yokota, Takashi Fujii, Kiyoaki Tsukahara, Mizuo Ando, Kenji Hanyu, Tsutomu Ueda, et al. Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. International journal of clinical oncology. 2022. 27. 1. 95-104
  • Shin Kariya, Yasushi Shimizu, Nobuhiro Hanai, Ryuji Yasumatsu, Tomoya Yokota, Takashi Fujii, Kiyoaki Tsukahara, Masafumi Yoshida, Kenji Hanyu, Tsutomu Ueda, et al. Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting. International journal of clinical oncology. 2021. 26. 6. 1049-1056
  • Nobuhiro Hanai, Yasushi Shimizu, Shin Kariya, Ryuji Yasumatsu, Tomoya Yokota, Takashi Fujii, Kiyoaki Tsukahara, Masafumi Yoshida, Kenji Hanyu, Tsutomu Ueda, et al. Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicentre retrospective clinical study. International journal of clinical oncology. 2021. 26. 5. 1005-1006
  • Nobuhiro Hanai, Yasushi Shimizu, Shin Kariya, Ryuji Yasumatsu, Tomoya Yokota, Takashi Fujii, Kiyoaki Tsukahara, Masafumi Yoshida, Kenji Hanyu, Tsutomu Ueda, et al. Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study. International journal of clinical oncology. 2021. 26. 3. 494-506
  • Ryutaro Hara, Naomi Kudo, Satoshi Suzuki, Tomoya Miura, Atsushi Matsubara. CD11c(+) dendritic cells coexpressing thymic stromal lymphopoietin receptor in animal model of eosinophilic otitis media. Asia Pacific allergy. 2020. 10. 4. e41
more...
MISC (19):
  • 松原篤, 高畑淳子, 工藤直美, 原隆太郎, 工藤玲子, 前田泰規, 山内一崇, 鈴木哲史. Diagnosis and treatment of eosinophilic otitis media. 月刊アレルギーの臨床. 2020. 545
  • 工藤直美. 好酸球性中耳炎の病態. 日本耳鼻咽喉科免疫アレルギー学会プログラム・抄録集. 2020. 38th
  • 原隆太郎, 工藤直美, 三浦智也, 松原篤. 好酸球性中耳炎モデルにおけるCD11c陽性樹状細胞の免疫組織学的検討. 日本耳鼻咽喉科免疫アレルギー学会プログラム・抄録集. 2020. 38th
  • 原隆太郎, 工藤直美, 鈴木哲史, 三浦智也, 松原篤. 好酸球性中耳炎モデルにおけるCD11c陽性樹状細胞. 日本耳鼻咽喉科免疫アレルギー学会プログラム・抄録集. 2019. 37th
  • 原隆太郎, 工藤直美, 鈴木哲史, 三浦智也, 松原篤. 好酸球性中耳炎モデルにおけるCD11c陽性樹状細胞の免疫組織学的検討. アレルギー. 2019. 68. 4/5
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page